The future of multiple sclerosis treatment
- PMID: 19200869
- DOI: 10.1016/S0022-510X(09)70015-2
The future of multiple sclerosis treatment
Abstract
Recent years have seen considerable evolution and increasing sophistication of our concepts of the pathophysiology of multiple sclerosis. These new notions include the increased recognition of the importance of extralesional pathology, of the interplay between inflammation and neurodegenerative changes, pathophysiological heterogeneity and additional immune cell populations contributing to disease. These advances have driven the development and evaluation of new therapeutic strategies and outcome measures for clinical trials. A sizeable number of new immunomodulatory and immunosuppressive agents are under development and attracting great attention. These may offer potential advantages over existing treatments in terms of convenience and efficacy, but certain agents may raise safety concerns. In addition, neuroprotective and repair strategies are beginning to be considered. Not all of these agents will eventually be marketed but they will all help us gain insight into the pathophysiology of multiple sclerosis and decipher the mechanisms that underlie its heterogeneity. The place that these therapies will come to occupy in future years will depend on their relative benefits and risks.
Similar articles
-
Toward the development of rational therapies in multiple sclerosis: what is on the horizon?Ann Neurol. 2007 Oct;62(4):314-26. doi: 10.1002/ana.21289. Ann Neurol. 2007. PMID: 17969020 Review.
-
Future neuroprotective strategies.Exp Neurol. 2010 Sep;225(1):40-7. doi: 10.1016/j.expneurol.2009.08.016. Epub 2009 Aug 27. Exp Neurol. 2010. PMID: 19716365 Review.
-
Translating new insights into treatment optimisation in multiple sclerosis.J Neurol Sci. 2009 Feb 1;277 Suppl 1:S1-2. doi: 10.1016/S0022-510X(09)70002-4. J Neurol Sci. 2009. PMID: 19200857 No abstract available.
-
The pathology of MS: new insights and potential clinical applications.Neurologist. 2007 Mar;13(2):45-56. doi: 10.1097/01.nrl.0000253065.31662.37. Neurologist. 2007. PMID: 17351524 Review.
-
Neuroprotection, regeneration and immunomodulation: broadening the therapeutic repertoire in multiple sclerosis.Trends Neurosci. 2010 Mar;33(3):140-52. doi: 10.1016/j.tins.2009.12.002. Epub 2010 Jan 4. Trends Neurosci. 2010. PMID: 20045200 Review.
Cited by
-
Vaccination and autoimmune diseases: is prevention of adverse health effects on the horizon?EPMA J. 2017 Jul 20;8(3):295-311. doi: 10.1007/s13167-017-0101-y. eCollection 2017 Sep. EPMA J. 2017. PMID: 29021840 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
